Does greater weight loss automatically mean better PCOS treatment?

No. Weight, glucose control, menstrual concerns and fertility goals are different outcomes. Evidence about one outcome should not be used as proof of superiority across all PCOS concerns without a relevant study addressing that claim. [1]

Does the 2023 guideline approve either product specifically for PCOS?

No. The guideline discusses anti-obesity options under general-population guidance for managing higher weight in adults with PCOS. That is different from an FDA indication for treating PCOS itself with either named product. [1, 2, 3]

Why should pregnancy plans be discussed before treatment?

The PCOS guideline emphasizes effective contraception when pregnancy is possible during GLP-1 treatment because pregnancy safety data are lacking. The chosen product also has its own instructions, so the discussion needs the actual prescription and future plans. [1]

What is a useful way to compare the options with my clinician?

Identify the main goal first, then ask what evidence supports each option for that goal, what follow-up would measure and what alternatives address other concerns. This is more useful than selecting a universal winner from a weight-loss headline.

Is tirzepatide better than semaglutide for PCOS and insulin resistance?

Medical reviewer of record:

Updated 2026-09-16

The 2023 international PCOS guideline does not establish a preference for tirzepatide over semaglutide. General obesity-trial results cannot settle a PCOS treatment decision. The clinician should match treatment to the actual goals and indications. ^{1, 2, 3}

The international PCOS guideline considers GLP-1 medications among options for managing higher weight alongside lifestyle care under general-population guidance. That is not an approval of either medicine specifically for PCOS.

Weight, glucose, menstrual symptoms, fertility plans, tolerability, and cost can lead to different priorities. Individual results vary.

Does greater average weight loss prove better PCOS care?

No. Weight change and PCOS-specific outcomes are different endpoints. Evidence needs to address the outcome relevant to the patient rather than treating every benefit as interchangeable.

Why do pregnancy plans matter?

The PCOS guideline emphasizes effective contraception when pregnancy is possible during GLP-1 treatment because pregnancy safety data are lacking. The exact product also has its own pregnancy and contraception instructions.

What should I ask my clinician?

Ask what condition the medication is intended to treat, what evidence supports that goal, and how response will be monitored. Other PCOS treatments may address different concerns.

Bottom line

Choose around the clinical problem and evidence. A broad ranking of the two drugs is not a personalized PCOS plan.

Compare semaglutide and tirzepatide

Frequently asked questions

Your hormones deserve better than guesswork

Online visits with licensed physicians
Estradiol, progesterone, HRT & sexual wellness
Lab panels at member pricing
FSA & HSA eligible with all plans

Learn more about women's health Get started

A smiling woman with dark hair in a cream sweater

From$65/mo

From price shown is the 12-month plan rate. Prices may vary.

Was this helpful?